التداخل بين إكسيميستان وباريكالسيتول

• Routine assessment of 25-hydroxy vitamin D levels prior to the start of aromatase inhibitor treatment should be performed ( 5.2 ).

Concomitant use of bisphosphonates, vitamin D supplementation, and calcium was not allowed.

Vitamin D Assessment Routine assessment of 25-hydroxy vitamin D levels prior to the start of aromatase inhibitor treatment should be performed, due to the high prevalence of vitamin D deficiency in women with early breast cancer (EBC).

Women with vitamin D deficiency should receive supplementation with vitamin D.